Sari Prutchi Sagiv
Keine laufenden Positionen mehr
Profil
Sari Prutchi Sagiv served as the Chief Executive Officer & Director at Promyco Diagnostics Ltd.
and as the Director-Tech Transfer at Mor Research Applications Ltd.
She also worked as the Principal at Ad4ever, Inc. and as the Chief Scientific Officer at Claritas Pharmaceuticals, Inc. Sagiv holds a graduate and doctorate degree from Tel-Aviv University and an undergraduate degree from Recanati School of Business Administration.
Ehemalige bekannte Positionen von Sari Prutchi Sagiv
| Unternehmen | Position | Ende |
|---|---|---|
| Mor Research Applications Ltd. | Corporate Officer/Principal | - |
| Ad4ever, Inc. | Corporate Officer/Principal | - |
| CLARITAS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Promyco Diagnostics Ltd.
 Promyco Diagnostics Ltd. Medical SpecialtiesHealth Technology Promyco Diagnostics has recognized the unmet need for sensitive and accurate serological diagnostic kits for the detection of genital mycoplasma infections. Promyco Diagnostics' research laboratories are located at Soroka University Medical Center, Beer Sheba, Israel. The development of its novel commercial kit is based on the extensive knowledge and expertise accumulated at the NationalCenter for Mycoplasma Laboratory, in the same institution, which specializes and centralizes the clinical testing of mycoplasma infections from samples throughout Israel. This Center was founded and lead for over 20 years by Promyco Diagnostics' scientific leader, Professor Shulamith Horowitz. Promyco Diagnostics' novel serological kit is already in use at this laboratory; many hundreds of samples have proved the concept behind its technology, which will be shortly translated into a simple and accurate commercial kit. The company was founded by Mor Research Applications, the technology transfer company of Israel's biggest Health Care Services, Kupat Holim Clalit, and Van Leer Ventures, one of the leading early stage investment centers. | Vorstandsvorsitzender | - |
Ausbildung von Sari Prutchi Sagiv
| Tel-Aviv University | Doctorate Degree |
| Recanati School of Business Administration | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CLARITAS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Mor Research Applications Ltd. | |
| Ad4ever, Inc. | |
Promyco Diagnostics Ltd.
Promyco Diagnostics Ltd. Medical SpecialtiesHealth Technology Promyco Diagnostics has recognized the unmet need for sensitive and accurate serological diagnostic kits for the detection of genital mycoplasma infections. Promyco Diagnostics' research laboratories are located at Soroka University Medical Center, Beer Sheba, Israel. The development of its novel commercial kit is based on the extensive knowledge and expertise accumulated at the NationalCenter for Mycoplasma Laboratory, in the same institution, which specializes and centralizes the clinical testing of mycoplasma infections from samples throughout Israel. This Center was founded and lead for over 20 years by Promyco Diagnostics' scientific leader, Professor Shulamith Horowitz. Promyco Diagnostics' novel serological kit is already in use at this laboratory; many hundreds of samples have proved the concept behind its technology, which will be shortly translated into a simple and accurate commercial kit. The company was founded by Mor Research Applications, the technology transfer company of Israel's biggest Health Care Services, Kupat Holim Clalit, and Van Leer Ventures, one of the leading early stage investment centers. | Health Technology |
